pmid,title,journal,year,drug,disease
39505795,"Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia.",Annals of hematology,2024,Imatinib,Hepatitis A
35596597,Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.,Hepatology communications,2022,Imatinib,Hepatitis A
31607749,Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours.,British journal of cancer,2019,Imatinib,Hepatitis A
25085666,Merkel cell carcinoma: current status of targeted and future potential for immunotherapies.,Seminars in cutaneous medicine and surgery,2014,Imatinib,Hepatitis A
15512829,Severe hepatitis and complete molecular response caused by imatinib mesylate: possible association of its serum concentration with clinical outcomes.,Leukemia & lymphoma,2004,Imatinib,Hepatitis A
